BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9811415)

  • 1. Rescue photochemotherapy for the treatment of acute cardiac rejection in the absence of cyclosporine maintenance therapy.
    DeNofrio D; Rosengard BR; Reynolds C; Acker MA; Rook AH; Loh E
    J Heart Lung Transplant; 1998 Oct; 17(10):1036-7. PubMed ID: 9811415
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
    Arbustini E; Dal Bello B; Rinaldi M; Diegoli M; Grasso M; Pellegrini C; Morbini P; Martinelli L; Bonora MR; Viganò M
    J Heart Lung Transplant; 1997 Sep; 16(9):982-4. PubMed ID: 9322152
    [No Abstract]   [Full Text] [Related]  

  • 3. Microangiopathic hemolytic anemia secondary to cyclosporine therapy in a heart and liver transplant recipient.
    Oteo JF; Alonso-Pulpón L; Diez JL; Camacho C; Expósito C; González A; Serrano-Fiz S
    J Heart Lung Transplant; 1996 Mar; 15(3):322-4. PubMed ID: 8777221
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical importance of grade 2 cellular heart rejection.
    el-Gamel A; Doran H; Rahman A; Deiraniya A; Campbell C; Yonan N
    J Heart Lung Transplant; 1996 Mar; 15(3):319-21. PubMed ID: 8777219
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study.
    Waid TH; Thompson JS; McKeown JW; Brown SA; Sekela ME
    J Heart Lung Transplant; 1997 Sep; 16(9):913-6. PubMed ID: 9322140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Quilty lesion in cardiac allografts: relationship to reduced endocardial cyclosporine A.
    Freimark D; Czer LS; Aleksic I; Ruan XM; Admon D; Blanche C; Trento A; Fishbein MC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1197-203. PubMed ID: 8719467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histologic changes of the myocardium after heart transplantation].
    Prochno T; Meyer R
    Z Arztl Fortbild (Jena); 1992 Oct; 86(20):1031-3. PubMed ID: 1441641
    [No Abstract]   [Full Text] [Related]  

  • 8. Photopheresis versus corticosteroids in the therapy of heart transplant rejection. Preliminary clinical report.
    Costanzo-Nordin MR; Hubbell EA; O'Sullivan EJ; Johnson MR; Mullen GM; Heroux AL; Kao WG; McManus BM; Pifarre R; Robinson JA
    Circulation; 1992 Nov; 86(5 Suppl):II242-50. PubMed ID: 1424007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of plasma cyclic GMP assay as a screening test for detection of acute cardiac allograft rejection.
    Stobierska-Dzierzek B; Surdacki A; Frasik W; Dziatkowiak A; Pietrucha A; Herman ZS; Piwowarska W
    J Heart Lung Transplant; 1998 Oct; 17(10):969-71. PubMed ID: 9811403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of endocardial lymphoid infiltrates (Quilty lesions) in nonheart transplant recipients treated with cyclosporine.
    Barone JH; Fishbein MC; Czer LS; Blanche C; Trento A; Luthringer DJ
    J Heart Lung Transplant; 1997 Jun; 16(6):600-3. PubMed ID: 9229289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grade 2 cellular heart rejection: does it exist?: Yes!
    Kemnitz J
    J Heart Lung Transplant; 1995; 14(4):800-1. PubMed ID: 7578197
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival after heart transplantation without regular immunosuppression.
    Ruygrok PN; Agnew TM; Coverdale HA; Whitfield C; Lambie NK
    J Heart Lung Transplant; 1994; 13(2):208-11. PubMed ID: 8031801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Performance and postoperative care of heart transplantation].
    Knosalla C; Hummel M; Loebe M; Weng Y; Grauhan O; Müller J; Hetzer R
    Dtsch Med Wochenschr; 1997 Nov; 122(46):1421-3. PubMed ID: 9417383
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of photopheresis in the rescue therapy of acute cellular rejection in human heart allografts: a preliminary clinical and immunopathologic report.
    Costanzo-Nordin MR; McManus BM; Wilson JE; O'Sullivan EJ; Hubbell EA; Robinson JA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):881-3. PubMed ID: 8442255
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathology of transplanted hearts.
    Billingham ME
    Semin Thorac Cardiovasc Surg; 1990 Jul; 2(3):233-40. PubMed ID: 2081231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
    Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we be doing routine biopsy after heart transplantation in a new era of anti-rejection?
    Patel JK; Kobashigawa JA
    Curr Opin Cardiol; 2006 Mar; 21(2):127-31. PubMed ID: 16470149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late acute cardiac allograft rejection: new therapeutic options?
    Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
    Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
    Chapman JR; Nankivell BJ
    Nephrol Dial Transplant; 2006 Aug; 21(8):2060-3. PubMed ID: 16728428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.